Acadian Asset Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.26M Sell
27,928
-54,709
-66% -$11.5M 0.01% 699
2025
Q4
$16.4M Buy
82,637
+58,304
+240% +$11.8M 0.03% 367
2025
Q3
$4.93M Buy
+24,333
New +$4.32M 0.01% 646
2025
Q1
Sell
-22,870
Closed -$2.88M 1812
2024
Q4
$2.88M Sell
22,870
-418,878
-95% -$62.3M 0.01% 683
2024
Q3
$73.4M Buy
441,748
+115,504
+35% +$17.5M 0.23% 118
2024
Q2
$43.4M Buy
326,244
+321,789
+7,223% +$38.7M 0.13% 151
2024
Q1
$468K Buy
4,455
+2,259
+103% +$203K ﹤0.01% 1025
2023
Q4
$165K Sell
2,196
-22,394
-91% -$1.42M ﹤0.01% 1270
2023
Q3
$1.62M Sell
24,590
-33,330
-58% -$2.49M 0.01% 747
2023
Q2
$4.71M Sell
57,920
-178,974
-76% -$12.7M 0.02% 477
2023
Q1
$14.1M Sell
236,894
-800,734
-77% -$44.5M 0.06% 255
2022
Q4
$50.6M Buy
1,037,628
+315,806
+44% +$14.6M 0.25% 111
2022
Q3
$37.2M Sell
721,822
-429,865
-37% -$25.5M 0.2% 125
2022
Q2
$60.5M Sell
1,151,687
-347,559
-23% -$24.2M 0.31% 96
2022
Q1
$129M Sell
1,499,246
-385,370
-20% -$31.7M 0.53% 49
2021
Q4
$154M Sell
1,884,616
-103,354
-5% -$7.55M 0.58% 51
2021
Q3
$132M Buy
1,987,970
+48,680
+3% +$3.45M 0.5% 63
2021
Q2
$130M Buy
1,939,290
+229,193
+13% +$14.2M 0.49% 59
2021
Q1
$88.9M Buy
1,710,097
+289,820
+20% +$14.7M 0.35% 81
2020
Q4
$56.7M Sell
1,420,277
-94,439
-6% -$3.05M 0.22% 96
2020
Q3
$37.1M Buy
1,514,716
+18,045
+1% +$461K 0.16% 137
2020
Q2
$27.1M Sell
1,496,671
-31,121
-2% -$613K 0.12% 174
2020
Q1
$22M Buy
1,527,792
+129,205
+9% +$3.71M 0.13% 151
2019
Q4
$53.2M Buy
1,398,587
+162,262
+13% +$4.86M 0.24% 104
2019
Q3
$27.3M Sell
1,236,325
-126,813
-9% -$2.7M 0.12% 174
2019
Q2
$28.2M Buy
1,363,138
+288,243
+27% +$6.64M 0.14% 154
2019
Q1
$31M Buy
1,074,895
+452,346
+73% +$11.2M 0.13% 154
2018
Q4
$10.7M Buy
622,549
+289,858
+87% +$7.02M 0.05% 253
2018
Q3
$9.47M Buy
332,691
+290,861
+695% +$9.6M 0.04% 291
2018
Q2
$1.41M Buy
41,830
+41,535
+14,080% +$1.29M 0.01% 656
2018
Q1
$7K Buy
295
+43
+17% +$856 ﹤0.01% 1592
2017
Q4
$4K Hold
252
﹤0.01% 1509
2017
Q3
$4K Hold
252
﹤0.01% 1354
2017
Q2
$5K Hold
252
﹤0.01% 1381
2017
Q1
$4K Sell
252
-44,358
-99% -$823K ﹤0.01% 1493
2016
Q4
$662K Buy
44,610
+44,128
+9,155% +$792K ﹤0.01% 797
2016
Q3
$11K Sell
482
-5,729
-92% -$149K ﹤0.01% 1234
2016
Q2
$171K Buy
6,211
+5,831
+1,534% +$172K ﹤0.01% 955
2016
Q1
$11K Sell
380
-14,777
-97% -$384K ﹤0.01% 1181
2015
Q4
$460K Buy
+15,157
New +$497K ﹤0.01% 823
2015
Q3
Sell
-2,848
Closed -$165K 1425
2015
Q2
$165K Buy
+2,848
New +$145K ﹤0.01% 957
2014
Q4
Sell
-57
Closed -$3K 1328
2014
Q3
$3K Buy
+57
New +$3.18K ﹤0.01% 1005

Other funds holding THC

Acadian Asset Management's THC Position: Q1 2026 in Review

Acadian Asset Management reduced its Tenet Healthcare (THC) stake by 66% in Q1 2026, selling an estimated $11.5M and leaving 27,928 shares worth $5.26M. The position accounts for 0.01% of the portfolio, ranked #699.

Acadian Asset Management first reported a position in THC in Q3 2014 and has held it in 42 quarters since. The position peaked at $154M in Q4 2021. 690 funds tracked by Wall St. Rank hold THC as of Q1 2026.

  • Acadian Asset Management held 27,928 shares of Tenet Healthcare worth $5.26M as of Q1 2026.
  • Acadian Asset Management sold 54,709 Tenet Healthcare shares in Q1 2026, an estimated $11.5M.
  • Tenet Healthcare made up 0.01% of Acadian Asset Management's portfolio in Q1 2026, its #699 holding.
  • Acadian Asset Management first reported a position in Tenet Healthcare in Q3 2014 and has held it in 42 quarters since.
  • Acadian Asset Management's Tenet Healthcare position peaked at $154M in Q4 2021.
  • 690 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.